Bio-Rad Labs (BIO) Tops Q3 EPS by $1.27
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $274.40 -2.39%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $3.71, $1.27 better than the analyst estimate of $2.44. Revenue for the quarter came in at $715.2 million versus the consensus estimate of $661.87 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
